Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease.
about
Gastroesophageal Reflux Disease Relief in Patients Treated with Rabeprazole 20 mg versus Omeprazole 20 mg: A Meta-AnalysisEvidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.Nonerosive Reflux Disease (NERD) - An Update.Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia.Proton pump inhibitor for non-erosive reflux disease: a meta-analysis.Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study.Personal view: rationale and proposed algorithms for symptom-based proton pump inhibitor therapy for gastro-oesophageal reflux disease.A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux disease.Systematic review: Is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease?Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients.Review article: alternative approaches to the long-term management of GERD.Review article: the role of acid suppression in patients with non-erosive reflux disease or functional heartburn.A review of rabeprazole in the treatment of acid-related diseasesA randomized, double blinded, clinical trial to assess the efficacy and cost effectiveness of omeprazole compared to rabeprazole in the maintenance therapy of patients with gastroesophageal reflux diseaseMaintenance treatment of gastroesophageal reflux disease: an evaluation of continuous and on-demand therapy with rabeprazole 20 mg.The efficacy and safety of proton-pump inhibitors in treating patients with non-erosive reflux disease: a network meta-analysis.Cost minimization of on-demand maintenance therapy with proton pump inhibitors in nonerosive gastroesophageal reflux disease.Effects of pantoprazole 20 mg in mildgastroesophageal reflux disease: Once-daily treatment in the acute phase, and comparison of on-demand versus continuous treatment in the long term.Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.Effect of rabeprazole and omeprazole on the onset of gastro-oesophageal reflux disease symptom relief during the first seven days of treatment.On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trial.Long-term treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: on-demand treatment compared with continuous treatment.On-demand therapy is a valid strategy in GERD patients: pros and cons.Persistence and adherence to proton pump inhibitors in daily clinical practice.Rabeprazole: a second-generation proton pump inhibitor in the treatment of acid-related disease.Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg.On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis
P2860
Q24289016-E7A8C2DD-E070-450C-B4EF-95B6AEDEF7AFQ30249468-F1C95985-B176-4AC7-B421-895D405BEFF0Q33890423-20218B49-0A3A-4F1D-B054-65B21FD084EDQ35010979-A0A4978B-C40E-4171-8F6B-65DD67E5004EQ35074278-1F70A2CA-E7E9-4362-8DF0-63D22334E17EQ35534109-61089787-703B-431D-9464-E786C8D882FDQ35857847-AB85B383-EE85-4F16-AD7D-B31A9F1ABD67Q35963755-EFB5EF6C-6F79-4D20-A1A1-724248BD8AA2Q35987877-352F47D0-D3AC-44E0-A504-5F89E0A5BF0DQ36149059-7A99C3FD-E3E6-41ED-8493-6F076BF6FE7BQ36319540-2C4FB416-6BA6-4DE1-8721-7C101D84D29DQ36398683-37BA9297-24FD-4D72-9C78-6A636CF6355CQ36661321-D4BC8D71-807F-4EEC-A706-E0999D53B346Q36817415-B0C6BEEE-4D5B-4557-A916-579ECD4702DFQ37135351-99AC6750-BA7B-4843-A5BD-2F68BCBBC905Q37223349-5F3E24BC-D864-40B3-B4FE-B2E4ECC34162Q37609380-7FCCAA8C-CD06-45E1-981C-40E0459734BEQ37661062-0D0C33A4-1F2B-4032-95C4-FD949CD5649AQ39276611-86D44AD1-D8F3-44BE-952F-52AE4215F8B2Q39345807-F9B835E4-1667-4C67-A5AB-97D317A5DEEBQ39363032-ECCF6BE9-E381-49E9-A4F2-DCD7497C753CQ39368773-253D94AD-028C-4642-95C9-7E757E067114Q40176045-A5C31F90-860D-4AB7-B0E8-A91A9FD70747Q43478583-88765161-3327-45FF-A793-9B2C73DE8209Q46203790-5727AA63-4C2E-409A-AA42-607F353AD248Q46718231-37554AFB-8697-4451-8879-DEE5C2851E90Q58787771-2A3485DC-B1AF-4310-BE07-B63876C484D8
P2860
Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Six-month trial of on-demand r ...... th non-erosive reflux disease.
@en
Six-month trial of on-demand r ...... th non-erosive reflux disease.
@nl
type
label
Six-month trial of on-demand r ...... th non-erosive reflux disease.
@en
Six-month trial of on-demand r ...... th non-erosive reflux disease.
@nl
prefLabel
Six-month trial of on-demand r ...... th non-erosive reflux disease.
@en
Six-month trial of on-demand r ...... th non-erosive reflux disease.
@nl
P2093
P2860
P1476
Six-month trial of on-demand r ...... th non-erosive reflux disease.
@en
P2093
D De Herdt
Trial Investigators
P2860
P304
P356
10.1111/J.1365-2036.2004.01999.X
P407
P577
2004-07-01T00:00:00Z